185 related articles for article (PubMed ID: 36583990)
1. Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
Chu Y; Milner J; Lamb M; Maryamchik E; Rigot O; Ayello J; Harrison L; Shaw R; Behbehani GK; Mardis ER; Miller K; Prakruthi Rao Venkata L; Chang H; Lee D; Rosenthal E; Kadauke S; Bunin N; Talano JA; Johnson B; Wang Y; Cairo MS
J Infect Dis; 2023 Mar; 227(6):788-799. PubMed ID: 36583990
[TBL] [Abstract][Full Text] [Related]
2. Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.
Bonifacius A; Tischer-Zimmermann S; Santamorena MM; Mausberg P; Schenk J; Koch S; Barnstorf-Brandes J; Gödecke N; Martens J; Goudeva L; Verboom M; Wittig J; Maecker-Kolhoff B; Baurmann H; Clark C; Brauns O; Simon M; Lang P; Cornely OA; Hallek M; Blasczyk R; Seiferling D; Köhler P; Eiz-Vesper B
Front Bioeng Biotechnol; 2022; 10():867042. PubMed ID: 35480981
[No Abstract] [Full Text] [Related]
3. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
5. Helminth antigens differentially modulate the activation of CD4
Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
[TBL] [Abstract][Full Text] [Related]
7. CD4
Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
[No Abstract] [Full Text] [Related]
8. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
Gupta S; Su H; Agrawal S
Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
[TBL] [Abstract][Full Text] [Related]
10. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
11. High Frequencies of Functional Virus-Specific CD4
Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
Front Immunol; 2021; 12():748881. PubMed ID: 34858405
[TBL] [Abstract][Full Text] [Related]
12. Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
Cooper RS; Fraser AR; Smith L; Burgoyne P; Imlach SN; Jarvis LM; Turner DM; Zahra S; Turner ML; Campbell JDM
Front Immunol; 2020; 11():598402. PubMed ID: 33488592
[TBL] [Abstract][Full Text] [Related]
13. Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.
Mahalingam SS; Jayaraman S; Arunkumar A; Dudley HM; Anthony DD; Shive CL; Jacobson JM; Pandiyan P
Front Immunol; 2023; 14():1231087. PubMed ID: 37799713
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-reactive IFN-γ-producing CD4
Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
[TBL] [Abstract][Full Text] [Related]
15. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.
Wang Y; Duan F; Zhu Z; Yu M; Jia X; Dai H; Wang P; Qiu X; Lu Y; Huang J
Cells; 2021 Dec; 11(1):. PubMed ID: 35011632
[TBL] [Abstract][Full Text] [Related]
16. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
[TBL] [Abstract][Full Text] [Related]
17. Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response.
Paolini A; Borella R; Neroni A; Lo Tartaro D; Mattioli M; Fidanza L; Di Nella A; Santacroce E; Gozzi L; Busani S; Trenti T; Meschiari M; Guaraldi G; Girardis M; Mussini C; Gibellini L; De Biasi S; Cossarizza A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887351
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4
Aiello A; Coppola A; Vanini V; Petrone L; Cuzzi G; Salmi A; Altera AMG; Tortorella C; Gualano G; Gasperini C; Scolieri P; Beccacece A; Vita S; Bruzzese V; Lorenzetti R; Palmieri F; Nicastri E; Goletti D
Int J Infect Dis; 2022 Sep; 122():841-849. PubMed ID: 35878802
[TBL] [Abstract][Full Text] [Related]
19. Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens.
Morhart P; Kehl S; Schuh W; Hermes K; Meltendorf S; Neubert A; Schneider M; Brunner-Weinzierl M; Schneider H; Lingel H
In Vivo; 2023; 37(1):70-78. PubMed ID: 36593041
[TBL] [Abstract][Full Text] [Related]
20. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
